Summary
Eli Lilly and Company (LLY) filed an 8-K on October 23, 2013, to report its third quarter and nine-month financial results for the period ending September 30, 2013. The filing primarily directs investors to a press release (Exhibit 99.1) and a teleconference for detailed information regarding operational and financial performance. Notably, the company highlighted its use of non-GAAP financial measures, such as non-GAAP net income and earnings per share, in its reporting. Lilly explained that these measures are intended to provide investors with a clearer view of ongoing operations by excluding highly variable and unpredictable items that could distort reported results. Management also utilizes these non-GAAP metrics for internal performance evaluation and resource allocation.
Key Highlights
- 1Company reported third quarter and nine-month financial results as of September 30, 2013.
- 2Detailed financial results are available via a press release (Exhibit 99.1) and a subsequent analyst teleconference.
- 3Lilly utilizes non-GAAP financial measures (e.g., non-GAAP net income, EPS) in its reporting.
- 4Non-GAAP measures are used to provide investors with insights into ongoing operations by excluding unpredictable items.
- 5Management uses non-GAAP measures for internal performance evaluation and resource allocation.
- 6The company cautions that non-GAAP measures should be considered alongside, not as a substitute for, GAAP measures.
- 7Prospective earnings guidance is subject to adjustments for unpredictable future matters.